Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

Therapeutic Innovation & Regulatory Science

Volumn 42, Issue 4, 2008, Pages 303-319

  Mallinckrod, Craig H ^a   Lane, Peter W ^b   Schnell, Dan ^c   Peng, Yahong ^d   Mancuso, James P ^e  

^a ELI LILLY AND COMPANY   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e PFIZER INC   (United States)

Author keywords

Clinical trials; Longitudinal data; Missing data; Primary analysis

Indexed keywords

EID: 84996206068     PISSN: 21684790     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150804200402     Document Type: Article

References (58)

1. Molenberghs G, Kenward MG. Missing Data in Clinical Studies. Chichester: John Wiley: 2007.
2. Gadbury GL, Coffey CS, Allison DB. Modern statistical methods for handling missing repeated measurements in obesity trials: beyond LOCF. Obes Rev. 2003; 4: 175–184.
3. Lane PW. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm Stat. (early view) 2007; DOI: 10.1002/pst.267.
4. Leon AC, Mallinckrodt CH, Chuang-Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biol Psychiatry. 2006; 59: 1001–1005.
5. Molenberghs G, Thijs H, Jansen I, et al Analyzing incomplete longitudinal clinical trial data. Biostatistics. 2004; 5: 445–464.
6. Liu G, Gould AL. Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat. 2002; 12: 207–226.
7. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-effects models. J Biopharm Stat. 2001; 11(1–2):9–21.
8. Mallinckrodt CH, Clark WS, David SR. Type I error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward. Drug Inf J. 2001; 35: 1215–1225.
9. Mallinckrodt CH, Sanger TM, Dube S, et al Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry. 2003; 53: 754–760.
10. Mallinckrodt CH, Clark SW, Carroll RJ, Molenberghs G. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations. J Biopharm Stat. 2003; 13: 179–190.
11. Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA. Clin Trials. 2004; 1: 477–489.
12. Mallinckrodt CH, Kaiser CJ, Watkin JG, Detke MJ, Molenberghs G, Carroll RJ. Type I error rates from likelihood-based repeated measures analyses of incomplete longitudinal data. Pharm Stat. 2004; 3: 171–186.
13. Mallinckrodt CH, Raskin J, Wohlreich MM, Watkin JG, Detke MJ. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANOVA in eight clinical trials. BMC Psychiatry. 2004; 4: 26.
14. Shen S, Beunckens C, Mallinckrodt C, Molenberghs G. A local influence sensitivity analysis for incomplete longitudinal depression data. J Biopharm Stat. 2006; 16: 365–384.
15. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997; 16: 2349–2380.
16. Little R, Rubin D. Statistical Analysis With Missing Data. New York: John Wiley; 1987.
17. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer; 2000.
18. Rubin DB. Inference and missing data. Biometrika. 1976; 63: 581–592.
19. Little RJA. Modeling the drop-out mechanism in repeated measures studies. J Am Stat Assoc. 1995; 90: 1112–1121.
20. Lavori PW. Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology. 1992; 6: 39–48.
21. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982; 38: 963–974.
22. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996; 52: 1324–1333.
23. Gibbons RD, Hedeker D, Elkin I, et al Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993; 50: 739–750.
24. Heyting A, Tolboom JT, Essers JG. Statistical handling of drop-outs in longitudinal clinical trials. Stat Med. 1992; 11: 2043–2061.
25. Lavori PW, Dawson R, Shera D. A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med. 1995; 14: 1913–1925.
26. Siddiqui O, Ali MW. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts. J Biopharm Stat. 1998; 8: 545–563.
27. Shao J, Zhong B. Last observation carry-forward and last observation analysis. Stat Med. 2003; 22: 2429–2441.
28. Carpenter J, Kenward M, Evans S, White I. Last observation carry-forward and last observation analysis. Letter to the Editor. Stat Med. 2004; 23: 3241–3244.
29. Cook RJ, Zeng L, Yi GY. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation. Biometrics. 2004; 60: 820–828.
30. Molenberghs G, Verbeke G. Models for Discrete Longitudinal Data. New York: Springer; 2005.
31. Beunckens C, Molenberghs G, Kenward MG. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials. 2005; 2: 379–386.
32. Rubin DB, Stern HS, Vehovar V. Handling “don't know” survey responses: the case of the Slovenian plebiscite. J Am Stat Assoc. 1995; 90: 822–828.
33. Hill JO, Hauptman J, Anderson JW, Fujioka K. O'Neil PM, Smith DK, Zavoral JH, Aronne LJ. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1 -yr study. Am J Clin Nutr. 1999; 69: 1108–1116.
34. Liang K, Zeger S. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhya: Indian J Stat. 2000; 62(Series B):134–148.
35. Molenberghs G, Kenward MG, Lesaffre E. The analysis of longitudinal ordinal data with non-random dropout. Biometrika. 1997; 84: 33–44.
36. Laird NM. Discussion to Diggle PJ, Kenward MG. Informative dropout in longitudinal data analysis. Appl Stat. 1994; 43: 84.
37. Rubin DB. Discussion to Diggle PJ, Kenward MG. Informative dropout in longitudinal data analysis. Appl Stat. 1994; 43: 80–82.
38. Copas JB, Li HG. Inference for non-random samples (with discussion). J Royal Stat Soc B. 1997; 59: 55–96.
39. Draper D. Assessment and propagation of model uncertainty (with discussion). J Royal Stat Soc B. 1995; 57: 45–97.
40. Kenward MG. Selection models for repeated measurements with non-random dropout: an illustration of sensitivity. Stat Med. 1998; 17: 2723–2732.
41. Diggle PD, Kenward MG. Informative dropout in longitudinal data analysis (with discussion). Appl Stat. 1994; 43: 49–93.
42. Rotnitzky A, Robins JM, Scharfstein DO. Semiparametric regression for repeated outcomes with nonignorable nonresponse. J Am Stat Assoc. 1998; 93: 1321–1339.
43. Little RJA. Pattern-mixture models for multivariate incomplete data. J Am Stat Assoc. 1993; 88: 125–134.
44. Little RJA. A class of pattern-mixture models for normal incomplete data. Biometrika. 1994; 81: 471–483.
45. Wu MC, Carroll RJ. Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process. Biometrics. 1988; 44: 175–188.
46. Ten Have TR, Kunselman AR. Pulkstenis EP, Landis JR. Mixed effects logistic regression models for longitudinal binary response data with informative drop-out. Biometrics. 1998; 54: 367–383.
47. Wu MC, Bailey KR. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics. 1989; 45: 939–955.
48. Mori M, Woodworth GG, Woolson RF. Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring. Stat Med. 1992; 11: 621–631.
49. Follmann D, Wu M. An approximate generalized linear model with random effects for informative missing data. Biometrics. 1995; 51: 151–168.
50. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001; 6: 330–351.
51. Lipkovich I, Duan Y, Ahmed S. Multiple imputation compared with restricted pseudo-likelihood and generalized estimating equations for analysis of binary repeated measures in clinical studies. Pharm Stat 2005; 4: 267–285.
52. Zhu HT, Lee SY. Local influence for incomplete-data models. J Royal Stat Soc B. 2001; 63: 111–126.
53. Verbeke G, Molenberghs G, Thijs H, Lesaffre E, Kenward MG. Sensitivity analysis for nonrandom dropout: a local influence approach. Biometrics. 2001; 57: 7–14.
54. Thijs H, Molenberghs G, Verbeke G. The milk protein trial: influence analysis of the dropout process. Biometric J. 2000; 42: 617–646.
55. Molenberghs G, Verbeke G, Thijs H, Lesaffre E, Kenward M. Mastitis in dairy cattle: local influence to assess sensitivity of the dropout process. Comput Stat Data Anal. 2001; 37: 93–113.
56. Troxel AB, Ma G, Heitjan DF. An index of local sensitivity to nonignorability. Statistica Sinica. 2004; 14: 1221–1237.
57. Ma G, Troxel AB, Heitjan DF. An index of local sensitivity to nonignorable drop-out in longitudinal modeling. Stat Med. 2005; 24: 2129–2150.
58. Ibrahim JG, Chen MH, Lipsitz SR, Herring AH. Missing-data methods for generalized linear models: a comparative review. J Am Stat Assoc. 2005; 100: 332–346.